LAURUSLABS
LAURUS LABS LIMITED
Each stock's 10,000-path forecast, rendered as light.
LAURUS LABS LIMITED (LAURUSLABS) Stock Analysis & Case Study
Is LAURUSLABS a good buy? The data-driven verdict.
LAURUS LABS LIMITED (LAURUSLABS) trades at ₹1,844,on the numbers it worth a closer look, a Downstox Snapshot Score of 56/100.
On the numbers, LAURUS LABS LIMITED (LAURUSLABS) worth a closer look, a Downstox Snapshot Score of 56/100, weighing expensive at 91.1× earnings, ROE of 18.3%, a 62% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
LAURUSLABS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How LAURUSLABS ranks against the 2,373 companies in our screener
- LAURUSLABS's market cap of 99,650 Cr ranks in the top 5% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- LAURUSLABS's book value of ₹98 ranks in the 52nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- LAURUSLABS's promoter holding of 27.5% ranks in the 6th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- LAURUSLABS's 3-year profit (PAT) growth of 4.0% ranks in the 33rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- LAURUSLABS's 3-year revenue growth of 4.0% ranks in the 32nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- LAURUSLABS's debt-to-equity ratio of 0.48x is lower than 36% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is LAURUSLABS overvalued? LAURUSLABS P/E vs peers
LAURUSLABS trades at 91.1× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
LAURUSLABS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.5y of LAURUSLABS history (31%/yr drift, 33%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| LAURUSLABS 2027 | ₹1,316 | ₹2,035 | ₹3,147 | +10% |
| LAURUSLABS 2028 | ₹1,216 | ₹2,245 | ₹4,144 | +22% |
| LAURUSLABS 2029 | ₹1,169 | ₹2,477 | ₹5,250 | +34% |
| LAURUSLABS 2030 | ₹1,155 | ₹2,733 | ₹6,465 | +48% |
| LAURUSLABS 2031 | ₹1,162 | ₹3,015 | ₹7,822 | +63% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability LAURUSLABS goes up, or doubles?
The bull case for LAURUSLABS
- LAURUSLABS's return on equity of 18.3% ranks in the 80th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A 10,000-path probability model puts a 62% chance the price is higher in a year, with a median target of ₹2,035 (+10%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹5,250.
The bear case & risks
- LAURUSLABS's P/E of 91.1x is lower than 12% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 18.8× price-to-book means most of the value is intangible/expectations, not assets on the books.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹1,169.
LAURUSLABS volatility & expected range, how bumpy is the ride?
Over the last 9.5 years LAURUSLABS compounded at 31%/year with annualized volatility of 33%. That volatility implies a 1-year 80% range of ₹1,316-₹3,147, the honest backbone behind any single price target.
LAURUSLABS price forecast, the full 60-month probability fan
LAURUSLABS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds LAURUSLABS hits common targets within the simulated horizon?
Full multi-horizon detail on the LAURUSLABS price target & forecast page.
LAURUSLABS Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. LAURUSLABS scores 6/8, mixed financial health.
LAURUSLABS MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy LAURUSLABS with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 26.93% | 3.7× |
| Zerodha | 25.90% | 3.9× |
| Groww | 25.98% | 3.8× |
| Dhan | 24.00% | 4.2× |
| Kotak Neo | 25.00% | 4.0× |
| Paytm MoneyCHEAPEST | 23.58% | 4.2× |
| Pocketful | 30.27% | 3.3× |
| Anand Rathi | 30.40% | 3.3× |
| Bajaj Broking | 25.00% | 4.0× |
| Share India | 30.49% | 3.3× |
Compare every broker on the LAURUSLABS MTF page.
About LAURUS LABS LIMITED: sector, index & market-cap context
LAURUS LABS LIMITED (LAURUSLABS) is a mid-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹99,650 Cr. See more stocks on our screener.
How the LAURUSLABS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of LAURUS LABS LIMITED's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
LAURUSLABS analysis, FAQs
Is LAURUS LABS LIMITED (LAURUSLABS) a good buy?
On the numbers, LAURUS LABS LIMITED (LAURUSLABS) worth a closer look, a Downstox Snapshot Score of 56/100, weighing expensive at 91.1× earnings, ROE of 18.3%, a 62% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is LAURUSLABS overvalued or undervalued?
LAURUSLABS trades at 91.1× earnings, expensive versus the ~22× long-run Nifty average.
What is the LAURUSLABS share price target for 2031?
LAURUSLABS's probability-weighted 2031 median target is ₹3,015, with an 80% range of ₹1,162-₹7,822 (10,000-path Monte-Carlo).
What is the probability LAURUSLABS doubles in 5 years?
The modelled probability of LAURUSLABS reaching ₹3,689 (2×) within 5 years is 39%.
What is the bull case for LAURUSLABS?
LAURUSLABS's return on equity of 18.3% ranks in the 80th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A 10,000-path probability model puts a 62% chance the price is higher in a year, with a median target of ₹2,035 (+10%).
What are the risks in LAURUSLABS?
LAURUSLABS's P/E of 91.1x is lower than 12% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 18.8× price-to-book means most of the value is intangible/expectations, not assets on the books.